BioTech IQ
  • Home
  • Podcast
  • Hiring?
  • Blog
  • Contact
Select Page
Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

Harnessing the Innate Immune System By Developing Three Types of iPSC-Derived Natural Killer Cells With Daniel Teper

by Ammon Rivera | Jul 15, 2022 | Podcast

  Companies in the biotech space are making contributions to help find a cure for cancer. Today’s guest is no exception. In today’s episode, Ammon Rivera sits down with Daniel Teper, Co-Founder and CEO of Cytovia Therapeutics, to talk about the unique technology...

Recent Posts

  • Biotech Chief People Officer Discusses How To Build Company Culture
  • Qualigen Therapeutics: Where It All Started And Where It’s Going With Founder And CEO Michael Poirier
  • Qualigen Therapeutics: How To Develop An Oncology Therapeutics Pipeline From A CMO’s Perspective With Tariq Arshad, MD
  • Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick
  • Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon

Recent Comments

  1. Ammon Rivera on Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?
  2. Andy blidy on Can Lineage Cell Therapeutics Proprietary Cell-Based Therapy Platform Change Treatment Development?

Follow BioTech IQ 

  • Follow
  • Follow
  • Follow
biotech logo black

187 W Main St,
Suite 203
Lehi, UT 84043

Biotech IQ © Copyright 2022. All Rights Reserved